Drug interactions and clinical pharmacokinetics

Area of Science:

• Pharmacology
• Drug Interactions
• Pharmacokinetics

Background:

• Drug interactions significantly impact drug efficacy and safety.
• Understanding pharmacokinetic processes is key to managing drug interactions.
• Clinical consequences range from altered therapeutic effects to increased toxicity.

Purpose of the Study:

• To review the mechanisms and clinical significance of pharmacokinetic drug-drug interactions.
• To differentiate between interactions affecting drug absorption rate versus amount.
• To highlight interactions involving protein binding, metabolism, and excretion.

Main Methods:

• Literature review of pharmacokinetic interactions.
• Analysis of drug absorption, distribution, metabolism, and excretion.
• Evaluation of clinical significance of protein binding displacement, enzyme induction/inhibition, and renal excretion competition.

Main Results:

• Interactions affecting gastro-intestinal absorption rate and amount are distinct.
• Protein binding displacement in vitro may not always translate to clinical significance.
• Hepatic enzyme inducers (e.g., barbiturates) and inhibitors significantly alter drug metabolism.
• Competition for renal tubular secretion is a clinically important interaction.

Conclusions:

• Pharmacokinetic drug interactions can lead to significant clinical outcomes.
• Careful consideration of drug absorption, metabolism, and excretion is necessary.
• Interactions involving hepatic metabolism and renal excretion are particularly clinically relevant.